Abstract
We prospectively evaluated relapse frequency and quality of life as assessed by the MS-QOL-54 questionnaire in 2 groups of relapsing-remitting MS patients with similar pre-treatment relapse rate and treated either with azathioprine or with beta IFN1b for one year. A marked reduction in relapse frequency occurred in both groups; no significant shifts occurred in the quality of life measurement. The results suggest further randomized studies of azathioprine and IFN beta in the therapy of relapsing-remitting MS.
Translated title of the contribution | Treatment with Interferon beta 1b and Azathioprine in the relapsing- remitting MS. Clinical and quality of life evaluation |
---|---|
Original language | Italian |
Pages (from-to) | 519-521 |
Number of pages | 3 |
Journal | Rivista di Neurobiologia |
Volume | 45 |
Issue number | 5-6 |
Publication status | Published - 1999 |
ASJC Scopus subject areas
- Neuroscience(all)